RR Animal Health Care Ltd.
2-3-144, Adarsh Nagar Colony, Nagole,
Hyderabad – 500 068, Telangana, India
To work as import substitution for Indian market
Hyderabad, India, February 15, 2021— RR Animal Health Care Ltd. is excited to share the news of development of our first Animal Pharma Active Pharmaceutical Ingredient (API) for poultry segment. With the development of Cyromazine 99.5% through an in-house developed route of synthesis, we became one of the first Animal Health Care company from India to develop this molecule with complete backward integration using a Green Chemistry route without the use of solvents.
Cyromazine, which is used as a Larvicide in Animal Health Care Industry, presently been imported mainly from China and most domestic suppliers were blending it with carrier material to prepare 1% or 2% formulated product. Many users and suppliers import the blended 2% product for their cost optimization.
This product shall work as an import substitution for Indian market. Presently with 3000 kg production capacity at a GMP certified facility in Hyderabad, India, which will be equivalent to nearly 150 tons of 2% formulation product, we are optimistic to supply to a large domestic customer base & export client. We promise to deliver a global standard product, readily availability in India across the year at an economical rate.
Our one small step towards Aatmanirbhar Bharat!!
About RR Animal Health Care Ltd.
RR Animal Health Care Ltd is a company with diversified interested in Animal and Human Health & Nutrition segment. With over 12 years of legacy, this company has established itself with unique solutions for Human, Poultry, Aqua and Livestock management in India. With 3 manufacturing facilities in India, the company is committed to deliver value to its customers across diversified species & segments. Pioneer in farm biosecurity segment with new concepts, the company is well recognized as a ‘Unique Solution Provider’ across industries. For more info: www.rrahc.in.